“…Benzoquinazolines, as the theme of much considerable interest research, have occupied a distinguished position in synthetic-pharmaceutical chemistry, because of their diverse range of pharmacological properties (Al-Salahi et al, 2016, Al-Salahi et al, 2017, Brullo et al, 2012). Several benzo[ h ]-,benzo[ g ]-and benzo[ f ] analogues of quinazolines were found to possess cytotoxic activities and used as tyrosine kinase inhibitors (Huijun, 2017, Nowak et al, 2014, Nowak et al, 2015, Markosyan et al, 2010, Pendergast et al, 1994, Alsaid et al, 2017, Sivalingam et al, 2017, Ghorab et al, 2016, Al-Salahi et al, 2015). For instance, 3-(4-methoxybenzyl)-6-(morpholin -4-yl)benzo[ h ]quinazolin-4(3 H )-one was reported to exhibit high cytotoxic effect against human colorectal adenocarcinoma cell lined HT29 with IC 50 value of 4.12 µM in relation to cisplatin (IC 50 = 8.47 µM) (Nowak et al, 2014).…”